Skip to main content

Viatris Inc(VTRS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada

Newswire.ca - Mon Apr 15, 5:59AM CDT

New generic Multiple Sclerosis treatment option, PrGlatiramer Acetate Injection 20 mg/mL for once-daily injection, available for one of the largest MS populations in the world

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe